NOT-HL-17-558: Notice of NHLBI Participation in PA-17-225 "Advancing the Science of Geriatric Palliative Care (R01)

Notice of NHLBI Participation in PA-17-225 "Advancing the Science of Geriatric Palliative Care (R01)"

Notice Number: NOT-HL-17-558

Key Dates
Release Date: November 9, 2017

Related Announcements
PA-17-225

Issued by
National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating in PA-17-225 “Advancing the Science of Geriatric Palliative Care (R01)”.

The following sections of PA-17-225 have been updated to reflect the participation of NHLBI in this Funding Opportunity Announcement (FOA):

Part 1. Overview

Components of Participating Organizations

National Institute on Aging (NIA)
National Center for Complementary and Integrative Health (NCCIH)
National Institute of Nursing Research (NINR)
National Institute on Minority Health and Health Disparities (NIMHD)
National Cancer Institute (NCI)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.866, 93.361, 93.307, 93.213, 93.393; 93.837, 93.838, 93.839, 93.840, 93.233

Part 2. Full Text of Announcement

Section I. Funding Opportunity Description

The following text is added:

Scope

National Heart, Lung, and Blood Institute (NHLBI)
The NHLBI is interested in studies that focus on how to better integrate and implement palliative care into the management of patients with heart, lung, blood, and sleep (HLBS) diseases. Studies that focus on HLBS patients with biologic, physiologic, functional, clinical, and/or psychosocial issues that accompany older age or HLBS patients with multiple chronic conditions would be responsive to this FOA.

Questions that could be addressed in response to this FOA could include, but are not limited to, the following:

How can patients with HLBS disease and families at high risk of having unmet palliative care needs be identified?
What key components of palliative care improve outcomes for HLBS patients and families, and what are the most effective ways to implement those components?
How can palliative care be integrated early in the course of disease for patients with chronic obstructive pulmonary disease (COPD), heart failure, and other chronic cardiopulmonary diseases, and does early integration improve patient outcomes and quality of life?
How can shared decision making, advanced care planning, and communication about goals of care be improved and implemented in the management of patients with pulmonary fibrosis, heart failure, and other chronic cardiopulmonary diseases?
What intensive care unit (ICU)-based palliative care models are most effective for acute respiratory failure and acute decompensated heart failure patients and their families, and how is this influenced by the ICU structure and/or culture?
How can high-quality palliative care be delivered by general cardiologists, heart failure specialists, primary care physicians, nurses, and other clinicians integrated within the heart failure team?
How can palliative care approaches for patients with myelodysplastic syndromes, including the delivery of chronic transfusions, be improved to meet the needs of patients and their caregivers?
How can palliative care be used most effectively to improve the quality of life for patients experiencing chronic incurable blood diseases, chronic graft versus host disease, or other morbidities post-hematopoietic stem cell transplant?
What are the barriers and facilitators to implementing palliative care for patients with HLBS diseases?

Part 2. Section VII. Agency Contacts

The following contact persons have been added:

Scientific/Research Contact(s)
Lora Reineck, MD, MS
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: [email protected]

Patrice Desvigne-Nickens, MD
Division of Cardiovascular Sciences
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0504
Email: [email protected]

Nahed El Kassar, MD, PhD
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8268
Email: [email protected]

Susan Shero, MS, RN
Center for Translational Research and Implementation Science
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-496-1051
Email: [email protected]

Financial/Grants Management Contact(s)
Anthony Agresti
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0186
Email: [email protected]

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Lora Reineck, MD, MS
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: [email protected]